Becton, Dickinson & Co. (BDX)
187.12
-0.99
(-0.53%)
USD |
NYSE |
Sep 01, 16:00
187.10
-0.02
(-0.01%)
Pre-Market: 20:00
Becton, Dickinson Research and Development Expense (Annual) : 1.265B for Sept. 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| September 30, 2025 | 1.265B |
| September 30, 2024 | 1.19B |
| September 30, 2023 | 1.237B |
| September 30, 2022 | 1.256B |
| September 30, 2021 | 1.279B |
| September 30, 2020 | 1.039B |
| September 30, 2019 | 1.004B |
| September 30, 2018 | 1.004B |
| September 30, 2017 | 774.00M |
| September 30, 2016 | 828.00M |
| September 30, 2015 | 632.00M |
| September 30, 2014 | 524.00M |
| September 30, 2013 | 494.00M |
| September 30, 2012 | 471.76M |
| September 30, 2011 | 469.52M |
| September 30, 2010 | 431.00M |
| September 30, 2009 | 408.13M |
| September 30, 2008 | 396.24M |
| September 30, 2007 | 360.05M |
| September 30, 2006 | 301.87M |
| September 30, 2005 | 271.63M |
| September 30, 2004 | 235.65M |
| September 30, 2003 | 235.06M |
| Date | Value |
|---|---|
| September 30, 2002 | 220.19M |
| September 30, 2001 | 211.83M |
| September 30, 2000 | 223.78M |
| September 30, 1999 | 205.22M |
| September 30, 1998 | 217.90M |
| September 30, 1997 | 165.88M |
| September 30, 1996 | 154.22M |
| September 30, 1995 | 144.20M |
| September 30, 1994 | 144.23M |
| September 30, 1993 | 139.14M |
| September 30, 1992 | 125.21M |
| September 30, 1991 | 113.04M |
| September 30, 1990 | 102.83M |
| September 30, 1989 | 97.54M |
| September 30, 1988 | 93.26M |
| September 30, 1987 | 82.15M |
| September 30, 1986 | 70.59M |
| September 30, 1985 | 59.93M |
| September 30, 1984 | 57.74M |
| September 30, 1983 | 55.15M |
| September 30, 1982 | 49.31M |
| September 30, 1981 | 43.52M |
| September 30, 1980 | 39.17M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Abbott Laboratories | 2.889B |
| Boston Scientific Corp. | 2.052B |
| Stryker Corp. | 1.567B |
| Baxter International, Inc. | 503.00M |
| Intuitive Surgical, Inc. | 1.312B |